166 related articles for article (PubMed ID: 29082818)
1. Studies into the anxiolytic actions of agomelatine in social isolation reared rats: Role of corticosterone and sex.
Regenass W; Möller M; Harvey BH
J Psychopharmacol; 2018 Feb; 32(2):134-145. PubMed ID: 29082818
[TBL] [Abstract][Full Text] [Related]
2. Social isolation rearing-induced anxiety and response to agomelatine in male and female rats: Role of corticosterone, oxytocin, and vasopressin.
Harvey BH; Regenass W; Dreyer W; Möller M
J Psychopharmacol; 2019 May; 33(5):640-646. PubMed ID: 30789294
[TBL] [Abstract][Full Text] [Related]
3. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety.
Rainer Q; Xia L; Guilloux JP; Gabriel C; Mocaër E; Hen R; Enhamre E; Gardier AM; David DJ
Int J Neuropsychopharmacol; 2012 Apr; 15(3):321-35. PubMed ID: 21473810
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.
Millan MJ; Brocco M; Gobert A; Dekeyne A
Psychopharmacology (Berl); 2005 Feb; 177(4):448-58. PubMed ID: 15289999
[TBL] [Abstract][Full Text] [Related]
5. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light.
Tchekalarova J; Stoynova T; Ilieva K; Mitreva R; Atanasova M
Pharmacol Biochem Behav; 2018 Aug; 171():1-9. PubMed ID: 29807067
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety.
Papp M; Litwa E; Gruca P; Mocaër E
Behav Pharmacol; 2006 Feb; 17(1):9-18. PubMed ID: 16377959
[TBL] [Abstract][Full Text] [Related]
7. Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action.
Millan MJ
Ther Adv Psychopharmacol; 2022; 12():20451253221105128. PubMed ID: 35795687
[TBL] [Abstract][Full Text] [Related]
8. Effect of agomelatine and its interaction with the daily corticosterone rhythm on progenitor cell proliferation in the dentate gyrus of the adult rat.
AlAhmed S; Herbert J
Neuropharmacology; 2010 Nov; 59(6):375-9. PubMed ID: 20685215
[TBL] [Abstract][Full Text] [Related]
9. Mild social stress abolishes the effects of isolation on anxiety and chlordiazepoxide reactivity.
Haller J; Halász J
Psychopharmacology (Berl); 1999 Jun; 144(4):311-5. PubMed ID: 10435402
[TBL] [Abstract][Full Text] [Related]
10. Effects of isolation-rearing on locomotion, anxiety and responses to ethanol in Fawn Hooded and Wistar rats.
Hall FS; Huang S; Fong GW; Pert A; Linnoila M
Psychopharmacology (Berl); 1998 Oct; 139(3):203-9. PubMed ID: 9784074
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam.
Ochoa-Sanchez R; Rainer Q; Comai S; Spadoni G; Bedini A; Rivara S; Fraschini F; Mor M; Tarzia G; Gobbi G
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):318-25. PubMed ID: 22789661
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant agomelatine attenuates behavioral deficits and concomitant pathology observed in streptozotocin-induced model of Alzheimer's disease in male rats.
Ilieva K; Tchekalarova J; Atanasova D; Kortenska L; Atanasova M
Horm Behav; 2019 Jan; 107():11-19. PubMed ID: 30452900
[TBL] [Abstract][Full Text] [Related]
13. Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats.
Morley-Fletcher S; Mairesse J; Soumier A; Banasr M; Fagioli F; Gabriel C; Mocaer E; Daszuta A; McEwen B; Nicoletti F; Maccari S
Psychopharmacology (Berl); 2011 Oct; 217(3):301-13. PubMed ID: 21503609
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN.
Tuma J; Strubbe JH; Mocaër E; Koolhaas JM
Eur Neuropsychopharmacol; 2005 Oct; 15(5):545-55. PubMed ID: 16139172
[TBL] [Abstract][Full Text] [Related]
15. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats.
Vitale G; Arletti R; Ruggieri V; Cifani C; Massi M
Peptides; 2006 Sep; 27(9):2193-200. PubMed ID: 16730097
[TBL] [Abstract][Full Text] [Related]
17. Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy.
Tchekalarova J; Atanasova D; Nenchovska Z; Atanasova M; Kortenska L; Gesheva R; Lazarov N
Neurobiol Dis; 2017 Aug; 104():1-14. PubMed ID: 28438504
[TBL] [Abstract][Full Text] [Related]
18. Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation.
Fone KC; Shalders K; Fox ZD; Arthur R; Marsden CA
Psychopharmacology (Berl); 1996 Feb; 123(4):346-52. PubMed ID: 8867874
[TBL] [Abstract][Full Text] [Related]
19. Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam.
Loiseau F; Le Bihan C; Hamon M; Thiébot MH
Eur Neuropsychopharmacol; 2006 Aug; 16(6):417-28. PubMed ID: 16376525
[TBL] [Abstract][Full Text] [Related]
20. Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus.
Lu Y; Ho CS; McIntyre RS; Wang W; Ho RC
Life Sci; 2018 Oct; 210():177-184. PubMed ID: 30193943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
